Showcasing the Canadian GRDI-AMR One Health Project: advancing genomics research for combatting antimicrobial resistance

Antimicrobial resistance (AMR) poses a significant threat to global health, demanding a collaborative and multi-sectoral approach to mitigate its impact. The Canadian Genomics Research and Development Initiative for Antimicrobial Resistance (GRDI-AMR) project exemplifies this approach by uniting a diverse team of experts from various Canadian science-based departments and agencies (SBDAs). This highly effective and collaborative team leverages the existing expertise within SBDAs, fostering innovation and driving advancements in AMR research. By integrating genomics and One Health principles, GRDI-AMR is generating critical knowledge and developing impactful solutions to combat AMR in Canada and beyond. This special issue provides a glimpse into the impactful outcomes generated by this collaborative network.